Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of relapse-associated gene mutations by next-generation sequencing in low-risk acute myeloid leukaemia patients.
Prieto-Conde MI, Jiménez C, García-Álvarez M, Ramos F, Medina A, Cuello R, Balanzategui A, Alonso JM, Sarasquete ME, Queizán JA, Alcoceba M, Bárez A, Puig N, Cantalapiedra A, Gutiérrez NC, García-Sanz R, González-Díaz M, Chillón MC. Prieto-Conde MI, et al. Among authors: cantalapiedra a. Br J Haematol. 2020 May;189(4):718-730. doi: 10.1111/bjh.16420. Epub 2020 Mar 2. Br J Haematol. 2020. PMID: 32124426 Free article.
Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study.
Jiménez C, Prieto-Conde MI, García-Álvarez M, Alcoceba M, Escalante F, Chillón MDC, García de Coca A, Balanzategui A, Cantalapiedra A, Aguilar C, Corral R, González-López T, Marín LA, Bárez A, Puig N, García-Mateo A, Gutiérrez NC, Sarasquete ME, González M, García-Sanz R. Jiménez C, et al. Among authors: cantalapiedra a. Ann Hematol. 2018 Mar;97(3):475-484. doi: 10.1007/s00277-017-3207-3. Epub 2018 Jan 20. Ann Hematol. 2018. PMID: 29353304
Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy.
Martínez C, Díaz-López A, Rodriguez-Calvillo M, García-Sanz R, Terol MJ, Pérez-Ceballos E, Jiménez MJ, Cantalapiedra A, Domingo-Domenech E, Rodriguez MJ, Sampol A, Espeso M, López FJ, Briones J, García JF, Sureda A; Hodgkin Lymphoma Subcommittee of Spanish Group of Lymphoma Bone Marrow Transplantation(GELTAMO). Martínez C, et al. Among authors: cantalapiedra a. Br J Haematol. 2016 Sep;174(6):859-67. doi: 10.1111/bjh.14133. Epub 2016 May 17. Br J Haematol. 2016. PMID: 27185197 Free article. Clinical Trial.
Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens.
Castaño-Bonilla T, Alonso-Dominguez JM, Barragán E, Rodríguez-Veiga R, Sargas C, Gil C, Chillón C, Vidriales MB, García R, Martínez-López J, Ayala R, Larrayoz MJ, Anguita E, Cuello R, Cantalapiedra A, Carrillo E, Soria-Saldise E, Labrador J, Recio I, Algarra L, Rodríguez-Medina C, Bilbao-Syeiro C, López-López JA, Serrano J, De Cabo E, Sayas MJ, Olave MT, Sánchez-García J, Mateos M, Blas C, López-Lorenzo JL, Lainez-Gonzalez D, Serrano J, Martínez-Cuadrón D, Sanz MA, Montesinos P. Castaño-Bonilla T, et al. Among authors: cantalapiedra a. Sci Rep. 2021 Oct 20;11(1):20745. doi: 10.1038/s41598-021-00050-x. Sci Rep. 2021. PMID: 34671057 Free PMC article.
[Incidence of haematological neoplasms in Castilla y León, Spain].
Rodríguez-García JA, Vázquez L, Ramos F, Cuevas B, Martín A, Smucler A, Guerola DN, Cantalapiedra A, Alonso JM, Fernández S, Díez E, Rodríguez MJ, Calmuntia MJ, Aguilar C, Sierra M, Gracia JA, Cebeira MJ, Cantalejo R; en nombre del Grupo de trabajo del Registro de Enfermedades Hematológicas de Castilla y León, Sociedad Castellano-Leonesa de Hematología y Hemoterapia. Rodríguez-García JA, et al. Among authors: cantalapiedra a. Med Clin (Barc). 2015 Jun 8;144(11):491-500. doi: 10.1016/j.medcli.2014.03.037. Epub 2014 Jul 9. Med Clin (Barc). 2015. PMID: 25015251 Spanish.
Emphysematous gastritis and severe aplastic anemia.
Gutierrez O, Cantalapiedra A, Tabuyo MI, Del Villar R, Peñarrubia MJ, Sales R, García-Frade LJ. Gutierrez O, et al. Among authors: cantalapiedra a. Hematol J. 2003;4(1):82-4. doi: 10.1038/sj.thj.6200200. Hematol J. 2003. PMID: 12692527 Review.
The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease.
Díaz-Agustín B, Escribano L, Bravo P, Herrero S, Nuñez R, Navalón R, Navarro L, Torrelo A, Cantalapiedra A, Del Castillo L, Villarrubia J, Navarro JL, San Miguel JF, Orfao A. Díaz-Agustín B, et al. Among authors: cantalapiedra a. Br J Haematol. 1999 Aug;106(2):400-5. doi: 10.1046/j.1365-2141.1999.01572.x. Br J Haematol. 1999. PMID: 10460598 Free article.
Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction.
Fernández-Avilés F, San Román JA, García-Frade J, Fernández ME, Peñarrubia MJ, de la Fuente L, Gómez-Bueno M, Cantalapiedra A, Fernández J, Gutierrez O, Sánchez PL, Hernández C, Sanz R, García-Sancho J, Sánchez A. Fernández-Avilés F, et al. Among authors: cantalapiedra a. Circ Res. 2004 Oct 1;95(7):742-8. doi: 10.1161/01.RES.0000144798.54040.ed. Epub 2004 Sep 9. Circ Res. 2004. PMID: 15358665 Clinical Trial.
43 results